| abstract |
A process for the preparation of cortexolone-17α-propionate in crystalline hydrate form IV, wherein the DRX spectrum is as presented in Figure 28, comprising crystallization of cortexolone-17α-propionate from a propylene glycol / water mixture or from a polyethylene glycol / water mixture. to obtain cortexolone-17α-propionate in crystalline hydrate form IV. The application contains 27 more claims. |